|
|
Article: ADVANCED INTERVENTIONAL SYSTEMS RECEIVES FDA PRE-MARKET APPROVAL
- Article from:
- PR Newswire
- Article date:
- January 31, 1992
CopyrightCOPYRIGHT 1992 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ADVANCED INTERVENTIONAL SYSTEMS RECEIVES FDA PRE-MARKET APPROVAL
First Laser Angioplasty System to Be Approved
for Coronary Laser Angioplasty
IRVINE, Calif., Jan. 31 /PRNewswire/ -- The federal Food and Drug Administration has granted pre-market (PMA) to Irvine-based Advanced Interventional Systems (NASDAQ: LAIS) for its DYMER(R) 200+ excimer laser angioplasty system. This is the first laser angioplasty system to be approved for use in the coronary arteries and makes this new technology available for widespread use throughout use the United States.
The DYMER 200+ is used to perform percutaneous excimer laser coronary angioplasty ...